All posts by: Michael Zand

About Michael Zand

Gene Therapy Advanced by Structural Study of Potential Viral Vectors – Genetic Engineering & Biotechnology News

Continue reading

2017-05-12 NEWS

Genetic Engineering & Biotechnology News

Gene Therapy Advanced by Structural Study of Potential Viral Vectors
Genetic Engineering & Biotechnology News
Scientists led by Associate Professor Vijay Reddy, Ph.D., at The Scripps Research Institute (TSRI) say they have discovered the structural details that make one virus a better tool for future therapies than a closely related virus. The team wrote in

and more »

Continue reading

2017-05-12 NEWS

Genetic Literacy Project

Is the US military in danger of using synthetic biology to ‘weaponize the environment’?
Genetic Literacy Project
… amount of money in these technologies as DARPA? The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: DARPA’s Synthetic Biology Initiatives Could Militarize the

Continue reading

2017-05-12 NEWS

pharmaphorum

The week that turned the cancer immunotherapy market on its head
pharmaphorum
This week may have produced a seismic shift in cancer immunotherapy as serious doubts emerged about Roche’s main contender, while solid phase 3 results boosted investor confidence in a late-to-market rival from AstraZeneca. Just days after a late-stage …
AstraZeneca Shows That With Immune Cancer Drugs, No One Knows What’s NextForbes
Key AstraZeneca drug shown to reduce risk of death from lung cancerKFGO
FTSE 100 boosted by AstraZeneca riseBBC News
Financial Times –Nasdaq –Citywire.co.uk
all 55 news articles »